Pharmaceutical Industry Veteran Further Strengthens the Executive Team BALTIMORE, MD, March 17, 2021 – AsclepiX Therapeutics, Inc., a biopharmaceutical company…
Read More
The technology could set new standards for data enrichment and patient-centric conduct of clinical trials February 23, 2021 08:00 ET…
BALTIMORE, MD, January 5, 2021 – AsclepiX Therapeutics, Inc., a biopharmaceutical company using computational biology to identify potent peptide regulators of…
BALTIMORE, MD, October 13, 2020 – AsclepiX Therapeutics, Inc., a biopharmaceutical company that uses computational biology to identify potent peptide regulators…
Proceeds to fund development of AXT107 for treatment of retinal diseases through Phase 1/2a clinical trials Series A financing led…
BALTIMORE, MD – AsclepiX Therapeutics, Inc., a biopharmaceutical company that uses computational biology to identify potent peptide regulators of vascular…
Recent Comments